Study for Naltrexone on the Abuse Potential of Methylphenidate
Phase 1
Completed
- Conditions
- NaltrexoneMethylphenidate Abuse
- Interventions
- Drug: PlaceboDrug: Treatment Phase Sequence 4213Drug: Treatment Phase Sequence 2134Drug: Treatment Phase Sequence 1342Drug: Treatment Phase Sequence 3421
- First Posted Date
- 2018-12-07
- Last Posted Date
- 2018-12-07
- Lead Sponsor
- Avekshan LLC
- Target Recruit Count
- 94
- Registration Number
- NCT03769064
- Locations
- 🇺🇸
Vince & Associates Clinical Research, Inc., Overland Park, Kansas, United States
© Copyright 2025. All Rights Reserved by MedPath